BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14626695)

  • 21. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
    Sebeo J; Hof PR; Perl DP
    Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease.
    Schiesling C; Kieper N; Seidel K; Krüger R
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):255-71. PubMed ID: 18447897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
    Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
    Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to diagnose dementia with Lewy bodies: state of the art.
    Geser F; Wenning GK; Poewe W; McKeith I
    Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuft-shaped astrocytes in Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
    Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical overview of the synucleinopathies.
    Martí MJ; Tolosa E; Campdelacreu J
    Mov Disord; 2003 Sep; 18 Suppl 6():S21-7. PubMed ID: 14502652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain magnetic resonance imaging (MRI) in parkinsonian disorders.
    Sitburana O; Ondo WG
    Parkinsonism Relat Disord; 2009 Mar; 15(3):165-74. PubMed ID: 19059803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson-related dementias.
    Boeve BF
    Neurol Clin; 2007 Aug; 25(3):761-81, vii. PubMed ID: 17659189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia.
    Jellinger KA
    Neurodegener Dis; 2008; 5(3-4):118-21. PubMed ID: 18322367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease. Diagnosis and the initiation of therapy.
    Bhat V; Weiner WJ
    Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease.
    Molina-Porcel L; Lladó A; Rey MJ; Molinuevo JL; Martinez-Lage M; Esteve FX; Ferrer I; Tolosa E; Blesa R
    Arch Neurol; 2008 Feb; 65(2):272-5. PubMed ID: 18268200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A 54-year-old man with familial parkinsonism, gaze palsy, and dementia].
    Shimura H; Mori H; Komatsuzaki Y; Nakamura K; Takanashi M; Hattori N; Mizuno Y
    No To Shinkei; 2005 Dec; 57(12):1104-12. PubMed ID: 16375198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin.
    Chang HT; Cortez S; Vonsattel JP; Stopa EG; Schelper RL
    Acta Neuropathol; 2004 Jul; 108(1):10-6. PubMed ID: 15108011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of clinical diagnosis of progressive supranuclear palsy.
    Osaki Y; Ben-Shlomo Y; Lees AJ; Daniel SE; Colosimo C; Wenning G; Quinn N
    Mov Disord; 2004 Feb; 19(2):181-9. PubMed ID: 14978673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.